Free Trial
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

$5.33
-0.16 (-2.91%)
(As of 07/12/2024 ET)
Today's Range
$5.31
$5.66
50-Day Range
$4.81
$7.51
52-Week Range
$4.64
$9.52
Volume
1.53 million shs
Average Volume
1.28 million shs
Market Capitalization
$2.04 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.80

LifeStance Health Group MarketRank™ Stock Analysis

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
65.1% Upside
$8.80 Price Target
Short Interest
Bearish
14.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.39mentions of LifeStance Health Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$24.01 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.26) to ($0.23) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.40 out of 5 stars

Medical Sector

726th out of 917 stocks

Health Services Industry

8th out of 10 stocks

LFST stock logo

About LifeStance Health Group Stock (NASDAQ:LFST)

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

LFST Stock Price History

LFST Stock News Headlines

Billionaire opens new pathway to wealth for investors
I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.
LifeStance Health Group Inc Ordinary Shares LFST
Billionaire opens new pathway to wealth for investors
I’ve been a financial analyst for almost three decades, but I don’t think I’ve ever seen anything quite like this before.
See More Headlines
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/09/2024
Today
7/13/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:LFST
Fax
N/A
Employees
9,325
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.80
High Stock Price Target
$10.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+65.1%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-186,260,000.00
Pretax Margin
-17.13%

Debt

Sales & Book Value

Annual Sales
$1.06 billion
Book Value
$3.77 per share

Miscellaneous

Free Float
357,057,000
Market Cap
$2.04 billion
Optionable
Optionable
Beta
1.20
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

LFST Stock Analysis - Frequently Asked Questions

How have LFST shares performed this year?

LifeStance Health Group's stock was trading at $7.83 at the beginning of 2024. Since then, LFST stock has decreased by 31.9% and is now trading at $5.33.
View the best growth stocks for 2024 here
.

How were LifeStance Health Group's earnings last quarter?

LifeStance Health Group, Inc. (NASDAQ:LFST) posted its earnings results on Thursday, May, 9th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.03. The business's revenue was up 18.9% compared to the same quarter last year.

When did LifeStance Health Group IPO?

LifeStance Health Group (LFST) raised $640 million in an initial public offering on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are LifeStance Health Group's major shareholders?

LifeStance Health Group's top institutional shareholders include SG Americas Securities LLC. Insiders that own company stock include Summit Partners Growth Equity, Michael K Lester, Gwen H Booth, Warren Gouk, Kevin Michael Mullins, Ryan Pardo, Danish J Qureshi, David Bourdon, Anisha Patel-Dunn, Paula Cipollone, Ann Varanakis and Jesse Michael Bruff.
View institutional ownership trends
.

How do I buy shares of LifeStance Health Group?

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFST) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners